Bioactive Compounds
-
L1021M DiscoveryProbe™ FDA-approved Drug Library MiniSummary: A unique collection of 1592 approved bioactive compounds. -
B5445 AT 56Summary: L-PGDS inhibitor -
B5471 MDL 72527Summary: polyamine oxidase (POA) inhibitor -
B5474 CP 20961Summary: non-immunogenic adjuvant -
B5514 ES 936Target: quinone oxidoreductaseSummary: NAD(P)H:quinone oxidoreductase inhibitor -
B5599 Fatostatin ASummary: sterol regulatory element binding protein (SREBP) inhibitor -
B5601 Ceranib 1Summary: ceramidase inhibitor -
B5603 YE 120Summary: GPR35 agonist -
B5635 T16Ainh - A01Summary: inhibitor of Ca2+-dependent Cl- channel (CaCC) transmembrane protein 16A (TMEM16A) -
B5636 CS 2100Summary: S1P1 agonist

